Actinium Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Actinium Pharmaceuticals (ATNM).

Price Target Range — 8 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$10Upside to Avg. PT+562.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Mar 31, 2026	Stephens & Co.	Sudan Loganathan	Maintained	Overweight	$5
Jun 24, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
May 12, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Apr 28, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Apr 1, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Mar 27, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Mar 25, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Mar 20, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Mar 18, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Mar 11, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Nov 19, 2024	Stephens & Co.	Sudan Loganathan	Maintained	Overweight	$5
Nov 15, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Aug 6, 2024	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$50→$4
Aug 6, 2024	Maxim Group	Jason McCarthy	PT Cut	Buy	$30→$5
Jul 26, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$50
Jun 17, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$50
May 21, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$50
May 14, 2024	Stephens & Co.	Sudan Loganathan	Initiate	Overweight	$25
May 2, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$50
Apr 30, 2024	Cantor Fitzgerald	Kristen Kluska	Maintained	Overweight	$21

Analyst Ratings News

PRO
Stephens & Co. Reiterates Overweight on Actinium Pharma, Maintains $5 Price Target

Stephens & Co. analyst Sudan Loganathan reiterates Actinium Pharma (AMEX:ATNM) with a Overweight and maintains $5 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.

Benzinga Newsdesk

Actinium Pharmaceuticals Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Actinium Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Stephens & Co. Reiterates Overweight on Actinium Pharma, Maintains $5 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

People Also Watch

People Also Watch

Actinium Pharmaceuticals Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Actinium Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROStephens & Co. Reiterates Overweight on Actinium Pharma, Maintains $5 Price Target

PROHC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PROHC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PROHC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PROHC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PROHC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

People Also Watch

People Also Watch

PRO
Stephens & Co. Reiterates Overweight on Actinium Pharma, Maintains $5 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target